atorvastatin and Cardiotoxicity
atorvastatin has been researched along with Cardiotoxicity in 6 studies
Research
Studies (6)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors
Authors | Studies |
---|---|
Abdel-Qadir, H; Amir, E; Billia, F; Brezden-Masley, C; Chan, J; Connelly, KA; Hanneman, K; Houbois, C; Huang, F; Kei, T; Marwick, TH; Maze, D; Pezo, RC; Power, C; Prica, A; Runeckles, K; Saha, S; Shalmon, T; Thavendiranathan, P; Thorpe, KE; Wintersperger, BJ | 1 |
Patrono, C; Pedicino, D | 1 |
Alenabi, A; Hallaj-Salahipour, M; Khoramjouy, M; Malekinejad, H; Malekinejad, M; Masoumi Verki, M | 1 |
Ahmed, LA; Attalla, DM; Khattab, MM; Zaki, HF | 1 |
Chen, W; Gao, G; Ge, L; Jiang, S; Sui, S; Zhai, C; Zhang, S | 1 |
Chen, J; Gao, L; Gao, X; He, X; Qi, Z; Zhang, K; Zhou, Y | 1 |
Trials
1 trial(s) available for atorvastatin and Cardiotoxicity
Article | Year |
---|---|
Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines.
Topics: Anthracyclines; Antibiotics, Antineoplastic; Atorvastatin; Biomarkers; Breast Neoplasms; Cardiotoxicity; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Stroke Volume; Ventricular Function, Left | 2023 |
Other Studies
5 other study(ies) available for atorvastatin and Cardiotoxicity
Article | Year |
---|---|
Adverse effects of anthracyclines: does atorvastatin STOP-CArdiotoxicity?
Topics: Anthracyclines; Antibiotics, Antineoplastic; Atorvastatin; Cardiotoxicity; Drug-Related Side Effects and Adverse Reactions; Humans; Neoplasms | 2023 |
Cardioprotective Effects of Atorvastatin Are Mediated Through PPARγ in Paraquat-Exposed Rats.
Topics: Animals; Antioxidants; Atorvastatin; Cardiotoxicity; Creatine Kinase, MB Form; Cyclooxygenase 2; Disease Models, Animal; Heart Diseases; Lipid Peroxidation; Male; Myocytes, Cardiac; Nitric Oxide; Oxidative Stress; Paraquat; Peroxidase; PPAR gamma; Rats, Wistar; Signal Transduction; Sulfhydryl Compounds | 2019 |
Paradoxical effects of atorvastatin in isoproterenol-induced cardiotoxicity in rats: Role of oxidative stress and inflammation.
Topics: Animals; Antioxidants; Atorvastatin; Biomarkers; Cardiotonic Agents; Cardiotoxicity; Heart; Inflammation; Isoproterenol; Male; Myocardial Infarction; Myocardium; Oxidative Stress; Rats; Rats, Wistar | 2018 |
Atorvastatin Improves Doxorubicin-Induced Cardiac Dysfunction by Modulating Hsp70, Akt, and MAPK Signaling Pathways.
Topics: Animals; Apoptosis; Atorvastatin; Cardiotoxicity; Caspase 3; Disease Models, Animal; Doxorubicin; Fibrosis; Heart Failure; Heart Ventricles; HSP70 Heat-Shock Proteins; Male; Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Atorvastatin Ameliorates Radiation-Induced Cardiac Fibrosis in Rats.
Topics: Animals; Atorvastatin; Cardiotoxicity; Dose-Response Relationship, Drug; Endomyocardial Fibrosis; Immunologic Factors; Male; Radiation Dosage; Radiation-Protective Agents; Radiation, Ionizing; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2015 |